Interim report January - September 2010
(Thomson Reuters ONE) -
* The Group's sales for the period amounted to SEK 412 (481) million.
* EBITDA amounted to SEK -37* (75) million.
* Operating profit totalled SEK -129** (58) million.
* The net profit after tax for the period amounted to SEK -163*** (16)
million.
* Earnings per share after tax for the period were SEK -0.48 (0.05) before
* and after dilution.
Significant events during the period
* Niklas Prager was elected as the new Chairman of the Board of BioPhausia.
* BioPhausia became the main supplier of parallel-imported pharmaceuticals to
Apoteksgruppen.
* Maris Hartmanis took up the position of BioPhausia CEO on 9 August.
* The Board decided to streamline operations and focus on the Nordic region.
* BioPhausia sold OTC products to Meda AB for SEK 190 million, which resulted
in a capital loss of SEK 74 mkr.
* Impairment losses of SEK 76 million were recognised for intangible assets
and SEK 17 million for inventories.
* Bank loan repayments totalled SEK 245 million during the period.
Period July - September
* The Group's sales for the period amounted to SEK 147 (148) million.
* EBITDA amounted to SEK -64* (21) million.
* Operating profit totalled SEK -120** (15) million.
* The net profit after tax for the period amounted to SEK -125*** (1) million.
* Earnings per share after tax for the period were SEK -0.36 (0.00 ) before
and after dilution.
*Includes non-recurring costs totalling SEK 99 million for the period and SEK
88 million for the quarter. For more information, see Note 7.
**Includes non-recurring costs totalling SEK 175 million for the period and SEK
140 million for the quarter. For more information, see Note 7.
***Includes non-recurring costs totalling SEK 186 million for the period and SEK
151 million for the quarter. For more information, see Note 7.
[HUG#1461598]
BioPhausia Interim report January - September 2010:
http://hugin.info/130049/R/1461598/400831.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioPhausia AB via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2010 - 15:00 Uhr
Sprache: Deutsch
News-ID 48682
Anzahl Zeichen: 2760
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 167 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Interim report January - September 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
BioPhausia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
